癌症治疗中组织不可知向的进展:当前的批准,挑战和未来的方向
Matthew Rubinstein1, Madeline Lauren Hong1, Rishi Kumar Nanda1
1College of Osteopathic Medicine, Touro University, Henderson, NV 89014, USA.
Oncology research
|November 3, 2025
概括
针对癌症突变的组织不可知疗法,无论起源如何,都在彻底改变瘤学. 研究正在进行中,以最大限度地提高患者的益处,并克服诸如瘤异质性和耐药性等挑战,以获得更广泛的治疗.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 精准医学是一门精准的医学.
背景情况:
- 组织不可知疗法向特定突变,而不是瘤位置,转变癌症治疗.
- 这些疗法代表了对精确瘤学的重大转变,为不同患者群体提供了新的希望.
研究的目的:
- 审查新兴组织不可知疗法的影响,安全性和挑战.
- 探索改进患者选择和改善生物标志物检测的策略.
- 突出泛组织学生物标志物在指导治疗决策中的作用.
主要方法:
- 关于当前组织不可知疗法和临床试验的文献综述.
- 对治疗疗效,安全性概况和耐药性机制的分析.
- 讨论生物标志物开发和患者选择策略.
主要成果:
- 组织不可知疗法在各种癌症类型中表现出有效性,为患者提供了显著的益处.
- 挑战包括内异质性和获得的耐药性,影响长期疗效.
- 像新抗原负担这样的新兴生物标志物对于患者分层至关重要.
结论:
- 组织不可知疗法是精密瘤学的变革性进步.
- 持续的研究对于优化治疗策略和克服接入障碍至关重要.
- 提高生物标志物测试的可访问性是实现这些疗法的全部潜力的关键.
相关概念视频
02:57Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
02:50Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K